• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Early initiation of poststernotomy cardiac rehabilitation exercise training is effective and safe

byKeerthana PasumarthiandAlex Chan
July 4, 2022
in Cardiology, Surgery
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Early cardiac rehabilitation following cardiac surgery involving median sternotomy was non-inferior to usual-care cardiac rehabilitation, suggesting similar levels of effectiveness and safety amongst both groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: There have been significant improvements in post-operative care and reduced complication rates in patients who have cardiac surgery requiring median sternotomy. Despite this, cardiac rehabilitation is often not initiated until six weeks post-sternotomy due to concerns regarding sternal healing following surgery. There remains ambiguity around indications for activity following sternotomy with no clear clinical recommendations, although some evidence does suggest that overly restrictive sternal precautions may contribute to poor health outcomes and subsequently support the earlier initiation of cardiac rehabilitation. As such, this randomized clinical trial aimed to investigate the effectiveness and safety of cardiac rehabilitation (CR) started two weeks after sternotomy (early CR) compared to CR started six weeks after (usual-care CR). A total of 158 participants from the United Kingdom who had coronary artery bypass graft and mitral or aortic valve replacement, recovering from median sternotomy were included. Participants were randomly assigned to early CR or usual-care CR groups and change in 6-minute walk test distance from baseline to after CR was assessed in all participants. The results of this study showed that early CR was not inferior to usual-care CR. In conclusion, this trial indicates that in patients receiving cardiac surgery involving median sternotomy, early cardiac rehabilitation is just as effective as usual-care cardiac rehabilitation. However, as this study was only conducted in two hospitals within the United Kingdom, these findings may not be generalizable to the greater population. Nonetheless, this study offers insights into effectiveness and safety of the earlier initiation of CR and warrants further research investigating long-term health outcomes and psychosocial benefits of earlier CR.

Click here to read the study in JAMA Cardiology

Relevant Reading: Effects of 12-Week Supervised Early Resistance Training (SEcReT) Versus Aerobic-Based Rehabilitation on Cognitive Recovery Following Cardiac Surgery via Median Sternotomy: A Pilot Randomized Controlled Trial

In-Depth [Randomized Control Trial]: The present study used data from patients aged 18 to 90 who had coronary artery bypass graft and cardiac valve replacement or repair, recovering from median sternotomy at two hospitals in the United Kingdom. To examine the efficacy and safety of early cardiac rehabilitation compared to usual-care cardiac rehabilitation following cardiac surgery involving sternotomy, 158 participants recovering from sternotomy were included. Early cardiac rehabilitation (CR) was started at two weeks and usual-care cardiac rehabilitation was started at six weeks. In both groups, participants completed eight weeks of twice-weekly, one-hour CR exercise training. The usual-care CR group completed a warm-up with light cardiovascular and mobility exercises followed by moderate-intensity continuous cardiovascular exercises such as cycling, rowing, or walking on the treadmill. The early CR group began rehabilitation with an individualized exercise program dictated by their current level of fitness and post-surgery symptoms; these participants were slowly transitioned to usual-care CR exercises once they were able to tolerate this. Participants were randomly assigned to either early CR or usual-care CR. Primary outcomes for this study included change in the six-minute walk test distance from baseline to after rehabilitation. Secondary outcomes included safety, functional fitness, and quality of life. Statistical analyses included linear regression. The results of this study showed that early CR was not inferior to usual-care CR. The noninferiority margin was 35m and the average change in 6-minute walk test distance was 28m higher in the early CR group compared to the usual-care CR group (95%CI, -11-66, P=0.16). Additionally, there was no statistically different change in safety, functional fitness, and quality of life between the two groups. This paper confirms that starting cardiac rehabilitation as early as two weeks post-sternotomy is as effective and safe as beginning CR six weeks after. Further research investigating benefits of early CR on psychosocial health, long-term health outcomes, and overall quality of life may be helpful in the prognosis of cardiac surgery patients receiving sternotomy.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

Image: PD

©2022  2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Cardiac surgerycardiologythoracics
Previous Post

2 Minute Medicine Rewind July 4, 2022

Next Post

FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option

RelatedReports

A senior woman looks thoughtfully at a balance scale with a stethoscope and a heart illustration, symbolizing the assessment of cardiovascular risk and treatment decisions.
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Atrial fibrillation collage: an engraved heart with teal upper chambers, paper sparks and a dotted teal ribbon around it
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Heart failure collage: an engraved heart with teal ventricles above a folded patchwork quilt, a teacup and house slippers
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Atrial fibrillation collage: an engraved heart with teal upper chambers, paper sparks and a dotted teal ribbon around it
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post

FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option

Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • PROT-001 was generally safe and well tolerated in a phase 1 study of healthy volunteers with AL amyloidosis
  • 2MM: AI Roundup- PTSD Prediction, Gait as a Biomarker, Faster Cardiac MRI, and Perinatal Mental Health Chatbots [November 12th, 2026]
  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.